着床前遺伝子検査の世界市場予測(~2022年):遺伝子診断、遺伝子スクリーニング

◆英語タイトル:Preimplantation Genetic Testing Market by Type (Genetic Diagnosis/Genetic Screening), Technology (NGS, PCR, FISH, CGH, SNP), Products & Services, Application (Aneuploidy, Translocations), End User (Fertility Clinics, Research) - Forecast to 2022
◆商品コード:MAM-BT5411
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2017年7月13日
◆ページ数:207
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、着床前遺伝子検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、バリューチェーン分析、市場環境分析、種類別分析、技術別分析、製品・サービス別分析、需要先別分析、着床前遺伝子検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global preimplantation genetic testing market is expected to reach USD 541.8 Million by 2022 from USD 336.4 Million in 2017, at a CAGR of 10.0%. The growth of this market is majorly driven by the rising rate of infertility across the globe, increasing number of fertility clinics worldwide, public-private investments in the field of preimplantation genetic testing, technological advancements in the field of genetic analysis, and the high risk of chromosomal abnormalities in the fetus with increasing maternal age.
The report analyzes the global preimplantation genetic testing market by technology, product & service, procedure type, application, end user, and region. Based on technology, the next-generation sequencing (NGS) segment accounted for the largest share owing to the advantages offered by NGS such as reduced cost, better ability to detect an embryo with differing results (mosaicism), enhanced detection of structural abnormalities such as chromosomes, and reduction in human errors due to increased automation.

By product & service, the reagents & consumables segment accounted for the largest market share owing to expanding application horizons of specific technologies (such as NGS and aCGH for whole-genome sequencing and FISH in the diagnosis of specific genetic disorders). Based on procedure type, the genetic screening segment accounted for the largest share due to continuous decline in female fertility (due to rising maternal age) and benefits offered by PGS, such as increased chances of healthy pregnancy across all age groups, better implantation rate, reduced risks of miscarriage, reduced IVF cycle time, and comprehensive analysis of all 24 chromosome types.

In terms of application, the aneuploidy segment held the largest share in 2016. Factors such as increasing maternal age and rising incidence of aneuploidy have led to the growth of this segment. Among end users, the maternity centers & fertility clinics segment accounted for the largest share of the global preimplantation genetic testing market due to factors such as increasing number of fertility centers and the high treatment success rate at such centers.

This report covers the preimplantation genetic testing market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global preimplantation genetic testing market in 2016, followed by Europe. The large share in the North American region is mainly attributed to the rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, and the ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS). The Asia-Pacific region is expected to register the highest growth rate during the forecast period, due to the growing focus of players on emerging markets and improvements in healthcare infrastructure in these regions.

The high procedural cost associated with preimplantation genetic testing and unsupportive government regulations are the key factors restraining the growth of this market.

Illumina, Inc. (U.S.) dominates the market through its wide range of technologically advanced and innovative preimplantation genetic testing products. The company adopts the strategy of agreements and partnerships to maintain its leadership position in the market.

Other prominent players in the preimplantation genetic testing market are Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), CooperSurgical, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), Abbott Laboratories (U.S.), Natera, Inc. (U.S.), Genea Limited (Australia), Rubicon Genomics, Inc. (U.S.), and Oxford Gene Technology (U.K.), among others.

【レポートの目次】

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Covered
1.3.1 Years Considered for the Study
1.4 Currency Used
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Methodology Steps
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Research Methodology: Bottom-Up Approach
2.2.2 Research Methodology: Top-Down Approach
2.3 Research Design
2.4 Data Validation and Triangulation
2.4.1 Assumptions for the Study

3 Executive Summary (Page No. – 30)

4 Premium Insights (Page No. – 38)
4.1 Preimplantation Genetic Diagnosis and Screening: Market Overview
4.2 Geographic Analysis: Preimplantation Genetic Diagnosis and Screening Market, By Technology (2016)
4.3 Preimplantation Genetic Testing Market , By Application, 2017 vs 2022
4.4 Preimplantation Genetic Testing Market , By Product & Service (2017 vs 2022)
4.5 Geographical Snapshot of the Preimplantation Genetic Diagnosis and Screening Market

5 Preimplantation Genetic Testing Market: Overview (Page No. – 43)
5.1 Introduction
5.2 Market Evolution: Preimplantation Genetic Diagnosis and Screening Technologies
5.3 Market Dynamics
5.3.1 Major Market Drivers
5.3.1.1 Declining Fertility Rates Worldwide
5.3.1.2 Increasing Public-Private Investments in the Field of Preimplantation Genetic Testing
5.3.1.3 Rising Number of Fertility Clinics Worldwide
5.3.1.4 Technological Advancements in the Field of Genetic Analysis
5.3.1.5 High Risk of Chromosomal Abnormalities With Advancing Maternal Age
5.3.2 Major Market Restraints
5.3.2.1 High Procedural Cost Associated With Preimplantation Genetic Testing
5.3.2.2 Unfavorable Government Regulations
5.3.3 Major Market Opportunities
5.3.3.1 Growth Opportunities in Emerging Markets
5.3.3.1.1 Improving Healthcare Infrastructure
5.3.3.1.2 Growing Medical Tourism
5.3.3.1.3 Growth Initiatives By Key Market Players
5.3.3.2 Growing Awareness on Assisted Reproduction Techniques
5.3.4 Major Market Challenges
5.3.4.1 Socioethical Concerns Regarding Preimplantation Genetic Testing
5.3.4.2 Procedural Limitations of Preimplantation Genetic Testing With Advancing Age

6 Industry Insights (Page No. – 58)
6.1 Value Chain Analysis
6.2 Porter’s Five Forces Analysis
6.3 Regulatory Scenario

7 Preimplantation Genetic Diagnosis and Screening Market, By Procedure Type (Page No. – 62)
7.1 Introduction
7.2 Preimplantation Genetic Screening
7.3 Preimplantation Genetic Diagnosis

8 Preimplantation Genetic Diagnosis and Screening Market, By Technology (Page No. – 66)
8.1 Introduction
8.2 Next-Generation Sequencing
8.3 Polymerase Chain Reaction
8.4 Fluorescence in Situ Hybridization
8.5 Comparative Genomic Hybridization
8.6 Single-Nucleotide Polymorphism

9 Preimplantation Genetic Diagnosis and Screening Market, By Product and Service (Page No. – 73)
9.1 Introduction
9.2 Reagents and Consumables
9.3 Instruments
9.4 Software and Services

10 Preimplantation Genetic Diagnosis and Screening Market, By Application (Page No. – 79)
10.1 Introduction
10.2 Aneuploidy
10.3 Structural Chromosomal Abnormalities
10.3.1 Translocations
10.3.2 Deletions
10.3.3 Duplications
10.3.4 Inversions
10.4 Single Gene Disorders
10.5 X-Linked Disorders
10.6 HLA Typing
10.7 Gender Identification

11 Preimplantation Genetic Diagnosis and Screening Market, By End User (Page No. – 92)
11.1 Introduction
11.2 Maternity Centers & Fertility Clinics
11.3 Hospitals, Diagnostic Labs, and Service Providers
11.4 Research Laboratories & Academic Institutes

12 Preimplantation Genetic Diagnosis and Screening Market, By Region (Page No. – 98)
12.1 Introduction
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.3 Europe
12.3.1 Germany
12.3.2 U.K.
12.3.3 France
12.3.4 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 Rest of Asia-Pacific
12.5 Rest of the World

13 Preimplantation Genetic Testing Market: Competitive Landscape (Page No. – 136)
13.1 Introduction
13.2 Leading Players in the Preimplantation Genetic Testing Market
13.3 Competitive Situation and Trends
13.3.1 Agreements, Collaborations, and Partnerships
13.3.2 Product Launches and Approvals
13.3.3 Acquisitions
13.3.4 Expansions
13.3.5 Other Developments
13.4 Global Preimplantation Genetic Diagnosis and Screening Competitive Leadership Mapping, 2017
13.4.1 Visionary Leaders
13.4.2 Innovators
13.4.3 Dynamic Differentiators
13.4.4 Emerging Companies
13.5 Competitive Leadership Mapping
13.5.1 Strength of Product Portfolio (For 25 Players)
13.5.2 Business Strategy Excellence (For 25 Players)

*Top 25 Companies Analysed for This Study are – Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Perkinelmer, Inc. (U.S.), Coopersurgical, Inc. (U.S.), ABBott Laboratories (U.S.), Natera, Inc. (U.S.), Rubicon Genomics, Inc. (U.S.), Oxford Gene Technology (U.K.), Yikon Genomics (China), Scigene (U.S.), Beijing Genomics Institute (China), Good Start Genetics (U.S.), Invicta Genetics (Poland), Combimatrix Corporation (U.S.), Genea Limited (Australia), Progenesis (U.S.), Arrayit Corporation (U.S.), Macrogen, Inc. (South Korea), Elucigene Diagnostics (U.K.), Reproductive Health Science Ltd. (Australia), Singlera Genomics, Inc. (U.S.), Igenomix (Spain), Source Bioscience (U.K.), Pacgenomics (U.S.)

14 Company Profiles (Page No. – 147)
(Overview, Products and Services, Financials, Strategy & Development)*
14.1 Top Product Manufacturers
14.1.1 Illumina, Inc.
14.1.2 Thermo Fisher Scientific Inc.
14.1.3 Agilent Technologies, Inc.
14.1.4 Perkinelmer, Inc.
14.1.5 Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)
14.1.6 ABBott Laboratories
14.1.7 Natera, Inc.
14.1.8 Rubicon Genomics (A Subsidiary of Takara Bio Usa Holdings, Inc.)
14.1.9 Oxford Gene Technology
14.1.10 Yikon Genomics
14.1.11 Scigene
14.2 Top Service Provider Companies
14.2.1 Beijing Genomics Institute
14.2.2 Good Start Genetics, Inc.
14.2.3 Invicta Genetics
14.2.4 Combimatrix Corporation
14.2.5 Genea Limited
14.2.6 Progenesis

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

15 Appendix (Page No. – 194)
15.1 Insights of Industry Experts
15.2 Discussion Guide
15.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
15.4 Introducing RT: Real-Time Market Intelligence
15.5 Available Customizations
15.6 Related Reports
15.7 Author Details

List of Tables (85 Tables)

Table 1 Global Incidence Rate of Trisomy (2014)
Table 2 Incidence Rate of Trisomy 21 in the U.S. (2014)
Table 3 Procedural Costs for Pgd & Pgs Testing Across Major Countries/Regions (2016)
Table 4 Average Cost of Pgs-Ivf Procedures in the U.S. (2016)
Table 5 Public Healthcare Expenditure (% of Annual GDP): 2005 vs 2014
Table 6 Global Regulations Governing Preimplantation Genetic Screening and Diagnosis (2016)
Table 7 Global Preimplantation Genetic Diagnosis and Screening Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 8 Preimplantation Genetic Screening Market Size, By Region, 2015–2022 (USD Million)
Table 9 Preimplantation Genetic Diagnosis Market Size, By Region, 2015–2022 (USD Million)
Table 10 Global Preimplantation Genetic Testing Market Size, By Technology, 2015–2022 (USD Million)
Table 11 Preimplantation Genetic Diagnosis and Screening Market Size for NGS, By Region, 2015–2022 (USD Million)
Table 12 Preimplantation Genetic Testing Market Size for Pcr, By Region, 2015–2022 (USD Million)
Table 13 Preimplantation Genetic Diagnosis and Screening Market Size for Fish, By Region, 2015–2022 (USD Million)
Table 14 Preimplantation Genetic Diagnosis and Screening Market Size for Cgh, By Region, 2015–2022 (USD Million)
Table 15 Preimplantation Genetic Testing Market Size for Snp, By Region, 2015–2022 (USD Million)
Table 16 Global Preimplantation Genetic Diagnosis and Screening Market Size, By Products & Services, 2015–2022 (USD Million)
Table 17 Preimplantation Genetic Diagnosis and Screening Market Size for Reagents and Consumables, By Region, 2015–2022 (USD Million)
Table 18 Preimplantation Genetic Testing Market Size for Instruments, By Region, 2015–2022 (USD Million)
Table 19 Preimplantation Genetic Diagnosis and Screening Market Size for Software and Services, By Region, 2015–2022 (USD Million)
Table 20 Global Preimplantation Genetic Diagnosis and Screening Market Size, By Application, 2015–2022 (USD Million)
Table 21 Accuracy of Pgs Techniques for Aneuploidy
Table 22 Preimplantation Genetic Testing Market Size for Aneuploidy, By Region, 2015–2022 (USD Million)
Table 23 Preimplantation Genetic Diagnosis and Screening Market for Structural Chromosomal Abnormalities, By Region, 2015–2022 (USD Million)
Table 24 Global Preimplantation Genetic Diagnosis and Screening Market for Structural Chromosomal Abnormalities, By Type, 2015–2022 (USD Million)
Table 25 Preimplantation Genetic Testing Market Size for Translocations, By Region, 2015–2022 (USD Million)
Table 26 Preimplantation Genetic Diagnosis and Screening Market Size for Deletions, By Region, 2015–2022 (USD Million)
Table 27 Preimplantation Genetic Testing Market Size for Duplications, By Region, 2015–2022 (USD Million)
Table 28 Preimplantation Genetic Diagnosis and Screening Market Size for Inversions, By Region, 2015–2022 (USD Million)
Table 29 Preimplantation Genetic Testing Market Size for Single Gene Disorders, By Region, 2015–2022 (USD Million)
Table 30 Preimplantation Genetic Diagnosis and Screening Market Size for X-Linked Disorders, By Region, 2015–2022 (USD Million)
Table 31 Preimplantation Genetic Diagnosis and Screening Market Size for HLA Typing, By Region, 2015–2022 (USD Million)
Table 32 Preimplantation Genetic Testing Market Size for Gender Identification, By Region, 2015–2022 (USD Million)
Table 33 Global Preimplantation Genetic Diagnosis and Screening Market Size, By End User, 2015–2022 (USD Million)
Table 34 Preimplantation Genetic Diagnosis and Screening Market Size for Maternity Centers & Fertility Clinics, By Region, 2015–2022 (USD Million)
Table 35 Preimplantation Genetic Testing Market Size for Hospitals, Diagnostic Labs, and Service Provider Companies, By Region, 2015–2022 (USD Million)
Table 36 Preimplantation Genetic Diagnosis and Screening Market Size for Research Laboratories & Academic Institutes, By Region, 2015–2022 (USD Million)
Table 37 Preimplantation Genetic Diagnosis and Screening Market Size, By Region, 2015-2022 (USD Million)
Table 38 North America: Major Pgd and Pgs Product Manufacturers and Service Provider Companies
Table 39 North America: Preimplantation Genetic Testing Market Size, By Country, 2015–2022 (USD Million)
Table 40 North America: Preimplantation Genetic Diagnosis and Screening Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 41 North America: Preimplantation Genetic Diagnosis and Screening Market Size, By Technology, 2015–2022 (USD Million)
Table 42 North America: Preimplantation Genetic Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 43 North America: Preimplantation Genetic Diagnosis and Screening Market Size, By Application, 2015–2022 (USD Million)
Table 44 North America: Preimplantation Genetic Diagnosis and Screening Market Size for Structural Chromosomal Abnormalities, By Type, 2015–2022 (USD Million)
Table 45 North America: Preimplantation Genetic Testing Market Size, By End User, 2015–2022 (USD Million)
Table 46 Regulations for Infertility Treatment Procedures in the U.S.
Table 47 U.S.: Preimplantation Genetic Testing Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 48 Canadian Laws on Infertility Treatment Procedures (As of 2016)
Table 49 Canada: Preimplantation Genetic Diagnosis and Screening Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 50 Europe: Major Pgd and Pgs Product Manufacturers and Service Provider Companies
Table 51 Europe: Preimplantation Genetic Testing Market Size, By Country, 2015–2022 (USD Million)
Table 52 Europe: Preimplantation Genetic Diagnosis and Screening Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 53 Europe: Preimplantation Genetic Diagnosis and Screening Market Size, By Technology, 2015–2022 (USD Million)
Table 54 Europe: Preimplantation Genetic Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 55 Europe: Preimplantation Genetic Diagnosis and Screening Market Size, By Application, 2015–2022 (USD Million)
Table 56 Europe: Preimplantation Genetic Diagnosis and Screening Market Size for Structural Chromosomal Abnormalities, By Type, 2015–2022 (USD Million)
Table 57 Europe: Preimplantation Genetic Testing Market Size, By End User, 2015–2022 (USD Million)
Table 58 Germany: Preimplantation Genetic Testing Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 59 U.K.: Preimplantation Genetic Testing Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 60 France: Preimplantation Genetic Diagnosis and Screening Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 61 RoE: Regulations for Infertility Treatment (As of 2016)
Table 62 RoE: Preimplantation Genetic Testing Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 63 Asia-Pacific: Major Pgd and Pgs Product Manufacturers and Service Provider Companies
Table 64 Asia-Pacific: Preimplantation Genetic Testing Market Size, By Country, 2015–2022 (USD Million)
Table 65 Asia-Pacific: Preimplantation Genetic Diagnosis and Screening Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 66 Asia-Pacific: Preimplantation Genetic Diagnosis and Screening Market Size, By Technology, 2015–2022 (USD Million)
Table 67 Asia-Pacific: Preimplantation Genetic Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 68 Asia-Pacific: Preimplantation Genetic Diagnosis and Screening Market Size, By Application, 2015–2022 (USD Million)
Table 69 Asia-Pacific: Preimplantation Genetic Diagnosis and Screening Market Size for Structural Chromosomal Abnormalities, By Type, 2015–2022 (USD Million)
Table 70 Asia-Pacific: Preimplantation Genetic Testing Market Size, By End User, 2015–2022 (USD Million)
Table 71 China: Preimplantation Genetic Testing Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 72 Japan: Preimplantation Genetic Diagnosis and Screening Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 73 India: Preimplantation Genetic Testing Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 74 RoAPAC: Preimplantation Genetic Diagnosis and Screening Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 75 RoW: Major Pgd and Pgs Product Manufacturers and Service Provider Companies
Table 76 RoW: Preimplantation Genetic Testing Market Size, By Procedure Type, 2015–2022 (USD Million)
Table 77 RoW: Preimplantation Genetic Diagnosis and Screening Market Size, By Technology, 2015–2022 (USD Million)
Table 78 RoW: Preimplantation Genetic Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 79 RoW: Preimplantation Genetic Diagnosis and Screening Market Size, By Application, 2015–2022 (USD Million)
Table 80 RoW: Preimplantation Genetic Diagnosis and Screening Market Size for Structural Chromosomal Abnormalities, By Type, 2015–2022 (USD Million)
Table 81 RoW: Preimplantation Genetic Testing Market Size, By End User, 2015–2022 (USD Million)
Table 82 Agreements, Collaborations, Partnerships, and Alliances 2014-2017
Table 83 Product Launches and Approvals, 2014–2017
Table 84 Acquisitions, 2014–2017
Table 85 Other Developments, 2014–2017

List of Figures (42 Figures)

Figure 1 Global Preimplantation Genetic Diagnosis and Screening Market: Research Methodology Steps
Figure 2 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation
Figure 4 Global Preimplantation Genetic Diagnosis and Screening Market Size, By Technology, 2017 vs 2022 (USD Million)
Figure 5 Global Preimplantation Genetic Testing Market Share, By Product & Service, 2017 vs 2022 (USD Million)
Figure 6 Global Preimplantation Genetic Diagnosis and Screening Market Size, By Procedure Type, 2017 vs 2022 (USD Million)
Figure 7 Global Preimplantation Genetic Testing Market Share, By Application, 2017 vs 2022 (USD Million)
Figure 8 Global Preimplantation Genetic Diagnosis and Screening Market Share, By End User, 2017 vs 2022 (USD Million)
Figure 9 Geographical Snapshot: Preimplantation Genetic Testing Market
Figure 10 Declining Fertility Rates & Technological Advancements in the Field of Genetic Analysis are Major Factors Driving Market Growth
Figure 11 NGS Accounted for the Largest Market Share in 2016
Figure 12 Aneuploidy Segment Dominates the Preimplantation Genetic Diagnosis and Screening Market
Figure 13 Reagents & Consumables Segment Will Continue to Dominate the Market in 2022
Figure 14 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 15 Drivers, Restraints, Opportunities, and Challenges
Figure 16 Global Female Fertility Rate (2004–2015)
Figure 17 U.S. Global Health Funding: Family Planning/Reproductive Health (2006–2016)
Figure 18 Value Chain Analysis: Preimplantation Genetic Diagnosis and Screening Industry (2016)
Figure 19 Porter’s Five Forces Analysis: Preimplantation Genetic Diagnosis and Screening Market (2016)
Figure 20 Federal Regulations in the U.S. on Genetic Testing (2016)
Figure 21 Preimplantation Genetic Diagnosis and Screening Market, By Procedure Type, 2017 vs 2022 (USD Million)
Figure 22 Preimplantation Genetic Testing Market Size, By Technology, 2017 vs 2022 (USD Million)
Figure 23 Preimplantation Genetic Diagnosis and Screening Market, By Products & Services, 2017 vs 2022 (USD Million)
Figure 24 Preimplantation Genetic Diagnosis and Screening Market Size, By Application, 2017 vs 2022 (USD Million)
Figure 25 Preimplantation Genetic Testing Market Size, By End User, 2017 vs 2022 (USD Million)
Figure 26 Preimplantation Genetic Diagnosis and Screening Market, By Region
Figure 27 Asia-Pacific to Grow at the Highest Rate During the Forecast Period
Figure 28 North America: Preimplantation Genetic Diagnosis and Screening Market Snapshot
Figure 29 Europe: Preimplantation Genetic Testing Market Snapshot
Figure 30 Asia-Pacific: Preimplantation Genetic Diagnosis and Screening Market Snapshot
Figure 31 RoW: Preimplantation Genetic Testing Market Snapshot
Figure 32 Global Preimplantation Genetic Diagnosis and Screening Market Ranking: Top 5 Players (2016)
Figure 33 Agreements, Partnerships, Collaborations, and Alliances—Majorly Adopted Growth Strategy By Market Players From 2014 to 2017
Figure 34 Global Preimplantation Genetic Diagnosis and Screening Competitive Leadership Mapping, 2017
Figure 35 Illumina, Inc.: Company Snapshot (2016)
Figure 36 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 37 Agilent Technologies, Inc.: Company Snapshot (2016)
Figure 38 Perkinelmer, Inc.: Company Snapshot (2016)
Figure 39 The Cooper Companies Inc.: Company Snapshot (2016)
Figure 40 ABBott Laboratories: Company Snapshot (2016)
Figure 41 Natera, Inc.: Company Snapshot (2016)
Figure 42 Combimatrix Corporation: Company Snapshot (2016)

【レポートのキーワード】

着床前遺伝子検査、遺伝子診断、遺伝子スクリーニング、着床前診断、着床前診断技術

★調査レポート[着床前遺伝子検査の世界市場予測(~2022年):遺伝子診断、遺伝子スクリーニング] (コード:MAM-BT5411)販売に関する免責事項を必ずご確認ください。
★調査レポート[着床前遺伝子検査の世界市場予測(~2022年):遺伝子診断、遺伝子スクリーニング]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆